Embecta Corp. (EMBC)
NASDAQ: EMBC · Real-Time Price · USD
4.750
-0.130 (-2.66%)
At close: Aug 12, 2026, 4:00 PM EDT
4.750
0.00 (0.00%)
After-hours: Aug 12, 2026, 7:34 PM EDT
Embecta Market Cap
Embecta has a market cap or net worth of $269.13 million as of August 12, 2026. Its market cap has decreased by -63.85% in one year.
Market Cap
269.13M
Enterprise Value
1.56B
1-Year Change
-63.85%
Ranking
Category
Stock Price
$4.75
ChartMarket Cap Chart
Since March 22, 2022, Embecta's market cap has decreased from $2.68B to $269.13M, a decrease of -89.94%. That is a compound annual growth rate of -40.71%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2026 | 269.13M | -61.74% |
| Dec 31, 2025 | 703.44M | -41.40% |
| Dec 31, 2024 | 1.20B | 10.14% |
| Dec 29, 2023 | 1.09B | -24.67% |
| Dec 30, 2022 | 1.45B | -45.94% |
| Mar 22, 2022 | 2.68B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Anteris Technologies Global | 864.43M |
| AngioDynamics | 650.99M |
| Anbio Biotechnology | 434.08M |
| Sanara MedTech | 315.43M |
| OraSure Technologies | 258.63M |
| Utah Medical Products | 230.63M |
| Pro-Dex | 215.22M |
| Nyxoah | 161.47M |